Allotment of 1,82,400 Equity Shares on Conversion of 60,800 Warrants

Fredun Pharmaceuticals has allotted 1,82,400 equity shares of face value Rs. 10/- each.

Sat 3 Oct 2026

Equity Shares Allotted

1,82,400 equity shares of face value Rs. 10/- each

Warrants Converted

60,800 convertible warrants

Allottees

10 non-promoter allottees

Warrant Issue Price

Rs. 1,250/- per warrant

Upfront Payment

Rs. 312.50/- per warrant, or 25% of the issue price

The Board of Directors of Fredun Pharmaceuticals Limited met on October 03, 2026 and allotted equity shares on conversion of warrants that had been issued earlier on a preferential basis.

What was allotted

• 1,82,400 fully paid-up equity shares of face value Rs. 10/- each, on conversion of 60,800 convertible warrants
• The warrant holders paid the balance consideration and applied to exercise their conversion rights
• The allotment is to non-promoter allottees, spread across 10 investors
• The shares will be allotted in dematerialised form and will rank pari passu with the existing equity shares in all respects

Backdrop

The warrants were allotted on December 29, 2025 on a preferential basis, pursuant to shareholder approval at an Extra-Ordinary General Meeting held on October 22, 2025. A total of 72,000 convertible warrants were allotted.

How the bonus issue changed the equation

After the company's 1:2 bonus issue, the entitlement on the outstanding warrants was proportionately adjusted, giving each warrant the right to the increased number of equity shares, with the exercise price revised accordingly. Accordingly, 60,800 outstanding warrants became exercisable into 1,82,400 equity shares, that is three equity shares for each outstanding warrant, upon payment of the applicable balance consideration.

Pricing

The warrants carried an issue price of Rs. 1,250/- per warrant. Of this, Rs. 312.50/- per warrant, being 25% of the issue price, was payable upfront, and the balance was paid before conversion.

Position after this allotment

The shareholding table in the update shows a total of 1,82,400 equity shares after the effect of the 1:2 bonus issue, with 2,667 warrants outstanding for conversion. The update also carries the allottee-wise break-up of warrants allotted, shares allotted on conversion and warrants outstanding.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.